FDA clears Empatica’s platform for Parkinson’s monitoring
August 19, 2026
Empatica’s platform enables continuous tracking of symptoms such as bradykinesia, dyskinesia and sleep quality.
Empatica’s platform enables continuous tracking of symptoms such as bradykinesia, dyskinesia and sleep quality.
WUXI, China, Aug. 19, 2026 /PRNewswire/ — NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) has granted both Breakthrough Therapy and Fast Track designations to NORROY’s 68Ga-NYM096, a potential radiopharmaceutical imaging agent targeting carbonic anhydrase Ⅸ (CAⅨ) for PET imaging of clear cell renal cell carcinoma (ccRCC).
BOSTON, Aug. 19, 2026 /PRNewswire/ — Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced that the Empatica Health Monitoring Platform for Parkinson’s has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Each year, roughly 2% to 5% of the population is affected by mitral valve prolapse (MVP) and mitral regurgitation (MR). These conditions can affect the heart’s rhythm and have been linked to sudden cardiac death, particularly in advanced stages of the disease, through the development of abnormal electrical activity. MVP causes the valve to bend backward as the heart contracts, while MR affects the valve’s ability to close fully, leading to blood leaking backward.
During cancer treatment, the same brain tumor can be treated with the same anticancer drug, but the effect can differ from patient to patient. A Korean research team has developed a chip that recreates a patient’s own tumor cells together with the surrounding peritumoral vascular environment, making it possible to predict patient-specific treatment responses in advance.
Researchers at the University of Southampton have developed a powerful AI tool that reveals previously invisible patterns inside breast cancers. It uncovers how tiny cellular structures called centrosomes change as tumors grow, spread and evolve. The technology could help clinicians identify high-risk patients, predict how breast cancer might progress and deliver more targeted treatments.
A new stem cell treatment for ARK (aniridia-related keratopathy) improved patients’ vision in a first-in-human clinical trial for this previously untreatable rare genetic eye condition at Moorfields Eye Hospital and University College London (UCL), published in JAMA Ophthalmology.
For people with severe lung diseases, a transplant of a healthy organ is often their only chance of survival. However, donor lungs are in short supply. A new artificial lung could provide a solution.
A protective layer that is extremely picky about not letting harmful substances in can sometimes also keep useful things from entering the very space it is meant to protect. The body’s blood-brain barrier (BBB) is one such case. Designed to keep harmful toxins and pathogens in the bloodstream from making their way into the brain while still allowing essential nutrients to pass through, the BBB has become a formidable foe for drugs that need to be delivered to the brain.
High blood pressure affects nearly 1 in 8 people worldwide, and its impact goes far beyond a number on a blood pressure monitor. It can quietly damage the heart, kidneys and brain, making it one of the world’s biggest preventable health threats.